Found: 10
Select item for more details and to access through your institution.
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231158231
- By:
- Publication type:
- Article
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231158231
- By:
- Publication type:
- Article
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221132363
- By:
- Publication type:
- Article
The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023399
- By:
- Publication type:
- Article
The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023399
- By:
- Publication type:
- Article
A Joint Effort: Improving the Identification of Spondyloarthritis in Patients With Inflammatory Bowel Disease.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 11, p. 3753, doi. 10.1007/s10620-020-06749-7
- By:
- Publication type:
- Article
Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States.
- Published in:
- Crohn's & Colitis 360, 2021, v. 3, n. 1, p. 1, doi. 10.1093/crocol/otab002
- By:
- Publication type:
- Article